CLINICAL RESEARCH
Proton magnetic resonance spectroscopy can detect creatine depletion associated with the progression of heart failure in cardiomyopathy
Ichiro Nakae, MD*,
Kenichi Mitsunami, MD ,*,
Tomoko Omura, MD*,
Takahiro Yabe, MD*,
Takayoshi Tsutamoto, MD*,
Shinro Matsuo, MD*,
Masayuki Takahashi, MD*,
Shigehiro Morikawa, MD ,
Toshiro Inubushi, PhD ,
Yasuyuki Nakamura, MD*,
Masahiko Kinoshita, MD* and
Minoru Horie, MD*
* Department of Cardiovascular and Respiratory Medicine, Seta, Otsu, Japan
Department of General Medicine, Medical Coordination Center, Seta, Otsu, Japan
Molecular Neuroscience Research Center, Shiga University of Medical Science, Seta, Otsu, Japan
Manuscript received July 9, 2002;
revised manuscript received November 19, 2002,
accepted May 7, 2003.
* Reprint requests and correspondence: Dr. Kenichi Mitsunami, Department of General Medicine, Medical Coordination Center, Shiga University of Medical Science, Seta, Otsu 520-2192, Japan. mitunami{at}belle.shiga-med.ac.jp
OBJECTIVES: This study noninvasively examined total creatine (CR) of the myocardium in dilated cardiomyopathy (DCM) or hypertrophic cardiomyopathy (HCM) using proton magnetic resonance spectroscopy (1H-MRS).
BACKGROUND: Abnormalities in CR metabolism in failing hearts have been reported. A biochemical study suggested that myocardial metabolic changes are very similar in DCM and HCM despite the different heart failure (HF) mechanisms.
METHODS: Using cardiac-gated 1H-MRS with magnetic resonance image (MRI)-guided point-resolved spectroscopy (PRESS) localization, we quantitatively measured septal CR. Patients with either DCM (n = 11) or HCM (n = 7) and age-matched normal subjects (n = 14) were examined.
RESULTS: Myocardial CR was significantly lower in DCM patients (16.1 ± 4.5 µmol/g wet weight [range 10.2 to 22.9], p < 0.05) than that in subjects with normal hearts (27.6 ± 4.1 µmol/g [range 21.4 to 36.2]). Myocardial CR in HCM patients (22.6 ± 8.1 µmol/g [range 12.2 to 34.5]) was significantly lower than that in subjects with normal hearts (p < 0.05) but was significantly higher than that in DCM patients (p < 0.05). In 18 patients with either DCM or HCM, myocardial CR correlated positively with left ventricular ejection fraction (LVEF) (y = 0.22x + 9.8, r = 0.73, p = 0.0006) but correlated negatively with plasma B-type natriuretic peptide (BNP) levels (y = 0.012x + 22.4, r = 0.54, p = 0.022).
CONCLUSIONS: This study showed that 1H-MRS can noninvasively detect CR depletion associated with the severity of HF in cardiomyopathy.
|
Abbreviations and Acronyms
| | BNP | = B-type natriuretic peptide | | CR | = creatine | | DCM | = dilated cardiomyopathy | | HCM | = hypertrophic cardiomyopathy | | HF | = heart failure | | 1H- and 31P-MRS | = proton and phosphorus-31 magnetic resonance spectroscopy, respectively | | LV | = left ventricular | | LVEF | = left ventricular ejection fraction | | MRI | = magnetic resonance imaging | | MRS | = magnetic resonance spectroscopy/spectroscopic | | NML(1) | = age-matched normal control group | | NML(2) | = nonage-matched larger normal control group | | NYHA | = New York Heart Association | | PCr | = phosphocreatine | | PRESS | = point-resolved spectroscopy | | STEAM | = stimulated-echo acquisition mode |
|
This article has been cited by other articles:

|
 |

|
 |
 
L. E. Hudsmith and S. Neubauer
Magnetic resonance spectroscopy in myocardial disease.
J. Am. Coll. Cardiol. Img.,
January 1, 2009;
2(1):
87 - 96.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Peluffo and R. Radi
Biochemistry of protein tyrosine nitration in cardiovascular pathology
Cardiovasc Res,
July 15, 2007;
75(2):
291 - 302.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Perseghin, G. Ntali, F. De Cobelli, G. Lattuada, A. Esposito, E. Belloni, T. Canu, F. Costantino, F. Ragogna, P. Scifo, et al.
Abnormal Left Ventricular Energy Metabolism in Obese Men With Preserved Systolic and Diastolic Functions Is Associated With Insulin Resistance
Diabetes Care,
June 1, 2007;
30(6):
1520 - 1526.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. S. Smith, P. A. Bottomley, S. P. Schulman, G. Gerstenblith, and R. G. Weiss
Altered Creatine Kinase Adenosine Triphosphate Kinetics in Failing Hypertrophied Human Myocardium
Circulation,
September 12, 2006;
114(11):
1151 - 1158.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Perseghin, P. Fiorina, F. De Cobelli, P. Scifo, A. Esposito, T. Canu, M. Danna, C. Gremizzi, A. Secchi, L. Luzi, et al.
Cross-Sectional Assessment of the Effect of Kidney and Kidney-Pancreas Transplantation on Resting Left Ventricular Energy Metabolism in Type 1 Diabetic-Uremic Patients: A Phosphorous-31 Magnetic Resonance Spectroscopy Study
J. Am. Coll. Cardiol.,
September 20, 2005;
46(6):
1085 - 1092.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. G. Weiss, G. Gerstenblith, and P. A. Bottomley
ATP flux through creatine kinase in the normal, stressed, and failing human heart
PNAS,
January 18, 2005;
102(3):
808 - 813.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. S. Ingwall and R. G. Weiss
Is the Failing Heart Energy Starved?: On Using Chemical Energy to Support Cardiac Function
Circ. Res.,
July 23, 2004;
95(2):
135 - 145.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. M. Pohost and J. R. Forder
From the atomic nucleus to man: Nuclear magnetic resonance spectroscopy, the next horizon in diagnostic cardiology
J. Am. Coll. Cardiol.,
November 5, 2003;
42(9):
1594 - 1595.
[Full Text]
[PDF]
|
 |
|
|